Immix Biopharma's total assets for Q1 2026 were $95.82M, a decrease of -8.61% from the previous quarter. IMMX total liabilities were $11.45M for the fiscal quarter, a 3.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.